{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T18:35:23Z","timestamp":1721241323300},"reference-count":36,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2012,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            A combination of drugs possessing different targets has been used as salvage therapy, although without scientific support.\n            <jats:italic>In vitro<\/jats:italic>\n            studies validating such combinations are scarce, and the methodology is very laborious and time-consuming. This study proposes a flow cytometric (FC) protocol as an alternative to evaluate the effect of the combination of anidulafungin (AND) with amphotericin B (AMB) and azoles (fluconazole and voriconazole), tested upon 39 and 36\n            <jats:named-content content-type=\"genus-species\">Candida<\/jats:named-content>\n            strains, respectively. The concentration assayed in the combination was 0.5\u00d7 MIC of each drug. The membrane potential marker DiBAC\n            <jats:sub>4<\/jats:sub>\n            (3) [Bis-(1,3-dibutylbarbituric acid) trimethine oxonol] was used for AND-AMB, and the metabolic marker FUN-1 was used for AND-azoles. Drug interaction was determined by calculating a staining index (SI): the sum of the percentage of depolarized cells (DC) after treatment with drug combinations divided by the DC of the drug alone, and the sum of the mean intensity of fluorescence (MIF) displayed by cells treated with drug combinations divided by the MIF of the drug alone for FUN-1. An SI of &lt;1 means antagonism, an SI between 1 and 4 means no interaction, and an SI of &gt;4 means synergism. The combination of AND and AMB by FC and checkerboard was synergistic for 46 and 43% of isolates and antagonistic for 5 and 8%, respectively. For the combination of AND and azoles, it was synergistic for 36% and antagonistic for 3% by FC and synergistic for 44% and antagonistic for 3% by checkerboard. When the FC method was compared to the gold standard checkerboard method, the agreement was 0.91 (95% confidence interval [95% CI] of 0.88 to 0.94), sensitivity was 0.88 (95% CI of 0.73 to 0.95), and specificity was 0.95 (95% CI of 0.84 to 1). Thus, FC is a rapid and reliable method (&lt;2 h) to assess the effect of antifungal combinations.\n          <\/jats:p>","DOI":"10.1128\/jcm.00610-12","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T04:57:14Z","timestamp":1339563434000},"page":"2748-2754","update-policy":"http:\/\/dx.doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":5,"title":["Novel Method for Evaluating\n            <i>In Vitro<\/i>\n            Activity of Anidulafungin in Combination with Amphotericin B or Azoles"],"prefix":"10.1128","volume":"50","author":[{"given":"R.","family":"Teixeira-Santos","sequence":"first","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, University of Porto, Portugal"}]},{"given":"R.","family":"Rocha","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, University of Porto, Portugal"},{"name":"Cardiovascular Research &amp; Development Unit, Faculty of Medicine, University of Porto, Portugal"}]},{"given":"A.","family":"Moreira-Ros\u00e1rio","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, University of Porto, Portugal"}]},{"given":"M.","family":"Monteiro-Soares","sequence":"additional","affiliation":[{"name":"Center for Research in Health Technologies and Information Systems (CINTESIS), Health Information and Decision Sciences Department (CIDES), Faculty of Medicine, University of Porto, Portugal"}]},{"given":"E.","family":"Cant\u00f3n","sequence":"additional","affiliation":[{"name":"Unidad de Microbiologia Experimental, Centro de Investigaci\u00f3n, Hospital Universitario La Fe, Valencia, Spain"}]},{"given":"A. G.","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, University of Porto, Portugal"},{"name":"Cardiovascular Research &amp; Development Unit, Faculty of Medicine, University of Porto, Portugal"},{"name":"Burn Unit, Department of Plastic and Reconstructive Surgery, Hospital S. Jo\u00e3o, Porto, Portugal"}]},{"given":"C.","family":"Pina-Vaz","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Faculty of Medicine, University of Porto, Portugal"},{"name":"Cardiovascular Research &amp; Development Unit, Faculty of Medicine, University of Porto, Portugal"},{"name":"Department of Microbiology, Hospital S. Jo\u00e3o, Porto, Portugal"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565110-00002"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00880-06"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qco.0000235166.16421.e5"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01510-09"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.5.2249-2251.2004"},{"key":"e_1_3_2_7_2","volume-title":"Approved standard M27-A.","author":"CLSI","year":"2008","unstructured":"CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts. Approved standard M27-A. CLSI, Wayne, PA."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh434"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mib.2008.04.006"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2009.02929.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.3.693-715.2004"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00330-10"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.10.014"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01131-08"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.1999.14.1.21"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/49.2.345"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.18.1.163-194.2005"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-008-0653-9"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg301"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3046.2005.00261.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.diagmicrobio.2010.08.013","article-title":"Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009)","volume":"69","author":"Pfaller MA","year":"2011","unstructured":"PfallerMA CastanheiraM MesserSA MoetGJ JonesRN. 2011. Echinocandin and triazole antifungal susceptibility profiles for Candida spp., Cryptococcus neoformans, and Aspergillus fumigatus: application of new CLSI clinical breakpoints and epidemiologic cutoff values to characterize resistance in the SENTRY Antimicrobial Surveillance Program (2009). Diagn. Microbiol. Infect. Dis. 69:45\u201350.","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00029-06"},{"key":"e_1_3_2_23_2","doi-asserted-by":"crossref","unstructured":"PfallerMA. 2011. Clinical breakpoints for the echinocandins and Candida revisited: integration of molecular clinical and microbiological data to arrive at species-specific interpretive criteria. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy. 14:164\u2013176.","DOI":"10.1016\/j.drup.2011.01.004"},{"key":"e_1_3_2_24_2","first-page":"281","article-title":"Evaluation of antifungal susceptibility using flow cytometry methods","volume":"638","author":"Pina-Vaz C","year":"2010","unstructured":"Pina-VazC RodriguesAG. 2010. Evaluation of antifungal susceptibility using flow cytometry methods. Mol. Biol. 638:281\u2013289.","journal-title":"Mol. Biol."},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-50-4-375"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1198-743x.2001.00307.x"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkq081"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.9.2320-2324.1997"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki218"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkm177"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh492"},{"key":"e_1_3_2_32_2","volume-title":"Medical statistics at a glance.","author":"Sabin C","year":"2000","unstructured":"SabinC PetrieA. 2000. Medical statistics at a glance. Blackwell Science, Malden, MA."},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01097-07"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.07.019"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.01.002"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.8.1914"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrmicro2133"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00610-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00610-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T20:37:35Z","timestamp":1646426255000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00610-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.1128\/JCM.00610-12"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00610-12","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"2012-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-06-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-07-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}